Lingyi Biotech Co., Ltd.
- Biotech or pharma, therapeutic R&D
Lingyi Biotech Co., Ltd. is a leading company in the development of next generation AAV gene therapy (AAV2.0) drugs for monogenic genetic diseases. The company is committed to original innovation, with a focus on clinically urgent areas such as metabolism, the central nervous system, and ophthalmology. By leveraging key technologies, including genetic disease animal models, the company aims to provide patients with comprehensive solutions.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}